(Press-News.org) PHOENIX, Ariz. — Jan. 13, 2011 — Genomic research could help doctors better target a drug widely used to treat colorectal cancer patients, according to a study by Genomic Health Inc. (Nasdaq: GHDX) and the Translational Genomics Research Institute (TGen).
The drug, oxaliplatin, is widely used in colon cancer. It is used in early disease, following surgery in those cancers that are likely to recur. It is also used in advanced disease to slow progression of the cancer where it has spread to other parts of the body.
However, a significant number of patients experience serious side effects, including prolonged damage to the nervous system, "creating an urgent need to identify genes that are responsible for drug sensitivity or resistance, which results in directing therapy to those most likely to benefit," according to the study published in Molecular Cancer Research.
Colorectal cancer is the third most common type of cancer in the U.S., annually diagnosed in more than 146,000 Americans. It also is the third highest cause of cancer death in the U.S., annually killing nearly 50,000 people, more than who die each year on the nation's roadways. This cancer affects men and women in nearly equal numbers.
Nerve damage, or neurotoxicity, associated with oxaliplatin is most commonly manifest as pain or a loss of sensation in the hands and feet and can severely affect a patient's quality of life and ability to work. These symptoms are experienced in some form by the majority of patients receiving this drug and, for some patients, can be permanent.
The TGen/Genomic Health researchers examined the role of individual cancer genes to influence the sensitivity or resistance of colon cancer cells grown in laboratory culture. An interfering RNA screen of 500 genes — with 2,000 unique siRNA sequences —identified 27 genes that, when silenced, altered the sensitivity of colon tumor cells to oxaliplatin, causing damage to the cancer cells' DNA and inhibiting the cancer cells' ability to reproduce and survive, the study said. This study has also showed that diverse gene networks also play a role in the ability of the drug to impact colon tumors.
"These 27 genes, whose loss of function significantly affect the effectiveness of oxaliplatin, may be promising therapeutic biomarkers for oxaliplatin," said Dr. Holly Yin, head of TGen's Cellular Genomics Collaborative Center in Scottsdale, and a co-author of the study.
Dr. Robert J. Pelham, a research scientist at Redwood City, Calif.-based Genomic Health and the study's senior author, said the findings indicate a need for additional clinical studies on tumor specimens in patients treated with oxaliplatin. "Such future clinical studies could eventually lead to potential clinical applications, where patients could benefit," Dr. Pelham said.
INFORMATION:
This laboratory study has been published online and is pending print publication in Molecular Cancer Research, one of six peer-reviewed scientific journals published by the Philadelphia-based American Association for Cancer Research. Founded in 1907, AACR is the world's oldest and largest scientific organization focused on high-quality, innovative cancer research.
About Genomic Health Inc.
Genomic Health, Inc. (NASDAQ: GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. As of September 30, 2010, more than 10,000 physicians in over 55 countries had ordered more than 175,000 Oncotype DX tests. Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of prostate and renal cell cancers, as well as additional stages of breast and colon cancers. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland. For more information, please visit www.genomichealth.com.
Press Contact:
650-569-2215
media@genomichealth.com
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org
The development and growth of much of Asia over the past two decades has been nothing short of spectacular. Yet, there remains a huge void of great brands (Japan aside) emerging from this region - Surveys repeatedly confirm that Asian consumers overwhelmingly prefer great Western brands to home-grown ones: given the choice, they will drink Coke, wear Nike shoes, and drive a BMW every time. This begets the question: How effective will be the current transition of the world order from West to East in the absence of great Asian brands? And will that momentous transition remain ...
iFunia, a professional developer of Mac multimedia software, is pleased to announce that their flagship product iFunia MOD Converter for Mac is currently available on the Mac App Store. iFunia MOD Converter is the multifunctional tool which helps camcorder enthusiasts easily convert MOD,TOD files recorded by most popular digital camcorder to all popular video and audio formats for use on Mac, iPad, iPhone or iPod, or Apple TV.
"With more than 1,000 free and paid apps, the Mac App Store brings the revolutionary App Store experience to the Mac, and we are thrilled to have ...
The Canadian Short Screenplay Competition, the most prestigious name in short film script contests, has earned one more honour: first place in the Writing and Literature category as part of the first edition of the Canadian Weblog Awards, a recently introduced annual event administered by Schmutzie.com, which was created to promote good weblogs of all genres from across Canada year round through regular interviews, articles, and the nomination, judging and award process that culminates with the announcement of the top three weblogs in each category on January 1st of each ...
Look what hatched on December 4, 2010: It's my bum2 book, a daily journal for TWINS!
With my bum2 [squared] book ("bum2"), parents of twins won't have to use two my bum books anymore! They can now record all their twins' daily deeds in one convenient book. "Bum2 was such a natural addition to the bum book line. I'd gotten so many requests for a twins' book - we just knew it would be a great way to help mothers with multiples make sense of their busy baby days." said Cory Kingston, founder.
For the same affordable price as the original my bum book ($19.95), the new ...
Improve the quality of your indoor air with houseplants as well as use them to brighten up a room. Plant leaves act as filters for many of the harmful toxins which are produced from carpet, paint, insulation and many other building materials found in our homes and offices.
To learn how to clean the air using indoor plants, come to Calloway's or Cornelius Nursery for a free "Dressing Your Indoors" Clinic Saturday, January 15, 2011, at 10:15 a.m. Stay for Repotting Day on January 15th which will be held all day from 9 a.m. to 6 p.m. We provide: the working space and tools, ...
An innovative new treatment performed by the chiropractors in San Diego at New Century Spine Centers is helping many victims of back pain. Spinal Decompression Therapy along with an Arthritis Relief Program also known as ARP is helping patients avoid surgery for back and neck pain in San Diego, CA. At a fraction of the cost of spinal surgery, Spinal Decompression Treatment is extremely safe, very effective, FDA cleared, and best of all, non-operative. Many patients describe the treatment as very safe and comfortable and the rehabilitation as very helpful in eliminating ...
CFO WISE Founder & CEO, Ken Kaufman, was given moderated the Focus Finance Round Table on January 6, 2011 on Effective Tax Strategies for Small and Medium-Sized Businesses.
This round table covered three main topics, recent tax law changes and how they impact you, actionable tips to help minimize tax and increase compliance, and an insider's perspective on how to get the most from your relationship with your CPA. The podcast for this discussion can be heard here.
About CFOwise
With over two centuries of senior-level executive experience, CFOwise is the premier ...
Woodycrest United Methodist and Nourishing NYC are pleased to announce Community Healthy Eating and Nutrition Classes for those in-need on February 16, 2011. In response to the scarcity of nutrition education within parts of New York City, Nourishing NYC and Woodycrest United Methodist will be offering a nutrition class free to those in-need on February 16th to help families and individuals that suffer disproportionately from poverty, obesity, and diabetes.
On February 16th, Nourishing NYC will be sending nutrition volunteers to Woodycrest United Methodist. The goal ...
Dr. Bedi of PSA Zero says, "Prostate cancer is one of the most common types of cancer prevalent in men. Prostate cancer is a slow grows slowly inside the prostate gland with hardly noticeable symptoms. Even though some early symptoms are apparent, men usually ignore it. It is pathetic to know most of the victims who are prone to prostate cancer are highly educated but they succumb to disease without awareness. He also added that if a person is well aware of the early symptoms then it is easy to cure the disease and prolong the life of the victim.
PSA Zero is a specially ...
Wind Simplicity's Windancer Small Wind Turbine Takes Gold at the Recycling Council Ontario (RCO) Waste Minimization Awards 2010.
Environmentalist and Windancer co-inventor Sharolyn Vettese won't allow any product with a skull and crossbones on the label through the doors of her manufacturing plant. A container sporting a decomposing hand won't get inside either.
She says the best way to minimize hazardous waste is not to generate it in the first place.
That's just one of the reasons she received a Gold Sustainable Product Award from the RCO for her small wind ...
